Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 11,018 shares at $31.54 ($350K) on 2022-02-16, disclosed to the SEC on 2022-02-18.
Open-market sale of $350k VIR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.54 | 5,000 | $158K | 45.1% |
| 2 | $31.93 | 3,009 | $96K | 27.5% |
| 3 | $31.93 | 3,009 | $96K | 27.5% |
| Total | $31.75 avg | 11,018 | $350K | 100% |
| Filing → |
| VIR | SELL | 2023-06-08 | $130K | — | Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |